NeuroDex Laboratory Services
Integrated clinical testing, clinical-trial support, and biomarker discovery under one roof
NeuroDex operates a fully integrated laboratory ecosystem purpose-built for neurological and neurodegenerative disease research, biomarker development, and clinical applications.
Our Labs
NeuroDex operates three integrated laboratories in Natick, Massachusetts, purpose-built for neurological and neurodegenerative disease: a CLIA-certified clinical testing laboratory, a GCLP-aligned clinical trial laboratory, and a research and development laboratory. Together they take neuron-derived blood biomarkers from discovery and assay development through clinical trials and clinical testing.
CLIA Clinical Testing Laboratory
Neuronal panel and medical testing services
Our CLIA-certified clinical testing laboratory develops and runs laboratory-developed tests (LDTs) for neurodegenerative and neurological conditions. Automated, high-precision workflows deliver reproducible, clinical-grade results from plasma and serum.
- Neuron-derived biomarker panels: TDP-43, α-synuclein, tau/pTau, NfL, AKT pathway, LC3/Cathepsin D, NF-κB and synaptic proteins
- EDTA plasma (serum also accepted), minimum 500 µL per sample
- Learn more about our neurodiagnostic platform
Clinical Trial Laboratory (GCLP-Compliant)
End-to-end support for clinical studies
Our GCLP-aligned clinical trial laboratory provides biomarker analysis from preclinical studies through Phase 2b trials, including multi-site, international and longitudinal studies, with traceability and consistency across batches.
- Serial samples analysed across every scheduled study visit
- Neuron-derived TDP-43 measured here was a registered primary outcome in the multinational Phase 2b PARADIGM ALS trial (NCT05357950)
- Reports typically 2–3 weeks after sample receipt. See our clinical trial services
Research & Development Laboratory
Advanced biomarker discovery and assay development
Our R&D laboratory is home to the ExoSORT™ platform, our automated immunoaffinity method for isolating neuron-derived extracellular vesicles from blood. It supports early-stage research, custom assay development and translational validation for academic and industry partners.
- Methods: immunoassays, PCR, RNA sequencing, proteomic and lipid mass spectrometry
- Qualified assays: TDP-43 variability below 20%, α-synuclein CV below 15%
- Custom target-engagement assays, including for ASO programs
Our laboratories at a glance
Working with our laboratories
- Scoping call to define your context of use, biomarkers and timepoints
- Assay selection, or custom assay development and qualification in human plasma
- Sample collection guidance for your sites; frozen plasma shipped on dry ice to Natick, MA
- Testing in the appropriate laboratory: CLIA, GCLP clinical trial, or R&D
- Data analysis and a report for your team, typically within 2–3 weeks of sample receipt
Frequently asked questions
Is NeuroDex’s laboratory CLIA certified?
Yes. NeuroDex operates a CLIA-certified clinical testing laboratory for laboratory-developed tests, alongside a GCLP-aligned clinical trial laboratory and a research and development laboratory, all following SOPs on GLP-compliant instruments.
Can your laboratory support multi-site and international clinical trials?
Yes. Our GCLP-aligned clinical trial laboratory supports multi-site, international and longitudinal studies from preclinical through Phase 2b, and analysed serial samples from every visit in the multinational Phase 2b PARADIGM ALS trial.
What samples does the laboratory accept?
EDTA plasma, with serum also accepted. The minimum volume is 500 µL per sample, shipped frozen on dry ice.
How long does testing take?
Reports are typically delivered 2–3 weeks after sample receipt, depending on study size.
Where are NeuroDex’s laboratories located?
All three NeuroDex laboratories are in Natick, Massachusetts.
Can your lab develop a custom biomarker assay for our target?
Yes. Our R&D laboratory develops and qualifies custom assays in human plasma neuron-derived vesicles, including target-engagement assays for ASO programs, and validates them for preclinical and clinical use.
Planning a study? Contact our team · NeuroDex FAQ · Publications

